全文获取类型
收费全文 | 87043篇 |
免费 | 7141篇 |
国内免费 | 1700篇 |
专业分类
耳鼻咽喉 | 737篇 |
儿科学 | 1967篇 |
妇产科学 | 1100篇 |
基础医学 | 3482篇 |
口腔科学 | 4502篇 |
临床医学 | 8367篇 |
内科学 | 10058篇 |
皮肤病学 | 1520篇 |
神经病学 | 5196篇 |
特种医学 | 3595篇 |
外国民族医学 | 21篇 |
外科学 | 9058篇 |
综合类 | 15602篇 |
现状与发展 | 8篇 |
一般理论 | 4篇 |
预防医学 | 6013篇 |
眼科学 | 1481篇 |
药学 | 8369篇 |
157篇 | |
中国医学 | 8828篇 |
肿瘤学 | 5819篇 |
出版年
2024年 | 95篇 |
2023年 | 1366篇 |
2022年 | 1868篇 |
2021年 | 3263篇 |
2020年 | 3783篇 |
2019年 | 2967篇 |
2018年 | 2794篇 |
2017年 | 3038篇 |
2016年 | 3317篇 |
2015年 | 3060篇 |
2014年 | 6026篇 |
2013年 | 8148篇 |
2012年 | 5898篇 |
2011年 | 6233篇 |
2010年 | 5286篇 |
2009年 | 4565篇 |
2008年 | 4090篇 |
2007年 | 4358篇 |
2006年 | 3928篇 |
2005年 | 3291篇 |
2004年 | 2758篇 |
2003年 | 2430篇 |
2002年 | 1992篇 |
2001年 | 1652篇 |
2000年 | 1408篇 |
1999年 | 1080篇 |
1998年 | 885篇 |
1997年 | 755篇 |
1996年 | 647篇 |
1995年 | 598篇 |
1994年 | 546篇 |
1993年 | 464篇 |
1992年 | 378篇 |
1991年 | 341篇 |
1990年 | 257篇 |
1989年 | 256篇 |
1988年 | 228篇 |
1987年 | 215篇 |
1986年 | 199篇 |
1985年 | 245篇 |
1984年 | 199篇 |
1983年 | 133篇 |
1982年 | 175篇 |
1981年 | 136篇 |
1980年 | 141篇 |
1979年 | 111篇 |
1978年 | 62篇 |
1977年 | 58篇 |
1976年 | 46篇 |
1975年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
目的观察使用聚甲酚磺醛溶液治疗外阴硬化性苔藓病变的临床疗效。方法对经临床诊断确诊为外阴硬化性苔藓病变且自愿接受本次研究的36例患者使用聚甲酚磺醛溶液,观察其疗效。结果36例外阴硬化性苔藓病变患者经过聚甲酚磺醛溶液3个月疗程治疗,痊愈率达76.9%,显效率为15.4%,有效率为7.7%。结论聚甲酚磺醛溶液能有效治疗外阴硬化性苔藓病变,无论是缓解瘙痒症状,还是改善病灶皮肤病变效果均较好,为广大临床医生提供了治疗此疾患的新思路。 相似文献
2.
《Journal of Radiology Nursing》2022,41(3):166-169
PurposeIn 2018, The Journal of Vascular and Interventional Radiology (JVIR) updated its guidelines regarding periprocedural antibiotics. However, some institutions are slower to adopt these new guidelines. Additionally, antibiotic-resistant bacteria and sepsis are serious concerns due in part to incorrect usage of antibiotics. The purpose of this study is to assess institutional adherence to 2018 JVIR guidelines for the purpose of improving antibiotic stewardship.Materials and methodsA total of 800 cases over a 10-month time period were retrospectively identified and charted following the release of guidelines. Inclusion criteria for the study were adults aged 21 years or older undergoing mediport placement, tunneled central line (TCL) placement, nephrostomy tube exchange, percutaneous biliary drain, or cholecystostomy tube exchange. Exclusion criteria included immunocompromised and pregnant individuals as 2018 guidelines may not fit these patient populations. Guideline adherence for each procedure was recorded as a percentage; the timing of the antibiotic usage was also recorded and compared to the guidelines (within 60 minutes before incision).ResultsIn total, 49 mediport placements, 118 tunneled central line placements – 44 hemodialysis (HD) catheters and 74 nonhemodialysis (non-HD) catheters, 100 nephrostomy exchanges, and 82 biliary tube exchanges were included. Antibiotics were used in 83.6% (41/49) of mediport patients, 11.3% (5/44) of non-HD TCL patients, 20.5% (15/74) of HD TCL patients, 55% (55/100) nephrostomy tube changes, and 65.4% (55/84) of biliary or cholecystostomy tube exchanges. Out of those given prophylaxis, guideline-recommended antibiotics were used in 100% (41/41) of mediport, 100% (20/20) of TCL (both HD and non-HD catheters), 9% (5/55) of nephrostomy tube exchanges, and 1.8% (1/55) of biliary tube exchanges. Guideline-recommended timing was followed in 75.3% across all cases (ranging from 72.2% in mediports to 79.3% in biliary exchanges).ConclusionThis study of antibiotic practices at a single university-based academic institution revealed that antibiotic usage is not fully up to date with 2018 guidelines. For mediports, non-HD TCL placements, and nephrostomy tube exchanges, institutional changes should be made to reduce periprocedural antibiotic use, as antibiotics are no longer recommended for these procedures. For HD TCL and biliary exchanges, proper adherence to recommended prophylactic antibiotics should be followed. In addition, education about the correct antibiotic timing should be emphasized to increase compliance with guidelines. 相似文献
3.
4.
5.
Biaoming Xu Yu Chen Mingjing Peng Jin Hai Zheng Chaohui Zuo 《International journal of cancer. Journal international du cancer》2023,152(2):110-122
Pancreatic cancer (PC) is a cancer of the digestive system, and pancreatic ductal adenocarcinoma (PDAC) accounts for approximately 90% of all PC cases. Exosomes derived from PDAC (PDAC-exosomes) promote PDAC development and metastasis. Exosomes are nanoscale vesicles secreted by most cells, which can carry biologically active molecules and mediate communication and cargo transportation among cells. Recent studies have focused on transforming exosomes into good drug delivery systems (DDSs) to improve the clinical treatment of PDAC. This review considers PDAC as the main research object to introduce the role of PDAC-exosomes in PDAC development and metastasis. This review focuses on the following two themes: (a) the great potential of PDAC-exosomes as new diagnostic markers for PDAC, and (b) the transformation of exosomes into potential DDSs. 相似文献
6.
7.
《Journal of vascular and interventional radiology : JVIR》2022,33(3):249-254.e1
An ovine iliac vein thrombosis model was devised to test a wall-contacting rotational thrombectomy device. Thrombosis was successfully induced in 9 sheep with an average clot length of 31 mm ± 12 and >60% vessel occlusion on angiography. The thrombus was subsequently removed, maintaining normal intraoperative pulmonary arterial pressure (5.9 mm Hg ± 3.6) and complete distal reperfusion after thrombectomy. Additionally, the sheep were without signs of vascular trauma or embolic complications on gross necropsy and histopathologic analysis. The findings from this study support the use of an ovine iliac deep vein thrombosis model for testing of a lower extremity thrombectomy device. 相似文献
8.
9.